Cingulate Inc.
NASDAQ:CINGBiotechnology
Healthcare
$5.11 -0.95%
-$0.05 today
- Market cap
- $76.46M
- Beta
- -0.91
- P/E (TTM)
- -1.0
- EPS (TTM)
- -$5.10
52W Low $3.16High $11.89
Volume 0.95M
Average 0.46M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$17.25M
FY 2025 · Annual
Investing Cash Flow
-$162,000.00
FY 2025 · Annual
Financing Cash Flow
$16.15M
FY 2025 · Annual
-47.6% YoYCash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (20.71M) | (17.68M) | (23.53M) | (15.55M) | (22.45M) |
| Depreciation & Amortization | 708.32K | 394.01K | 582.92K | 653.09K | 540.89K |
| Deferred Income Tax | (16.26M) | (797.96K) | 0 | 0 | 0 |
| Stock-Based Compensation | 12.78M | 800.8K | 812.67K | 995.48K | 0 |
| Change in Working Capital | (3.21M) | 598.62K | 7.1M | (4.55M) | 830.85K |
| Accounts Receivables | (1.86M) | 1.25M | 219.81K | (11.7K) | 18.31K |
| Inventory | 0 | (1.25M) | 0 | 0 | 0 |
| Accounts Payables | 0 | 791.01K | 0 | 0 | 0 |
| Other Working Capital | (1.35M) | (192.39K) | 6.89M | (4.54M) | 812.54K |
| Other Non-Cash Items | 16.26M | 797.96K | 0 | 0 | 3.83M |
| Operating Cash Flow | (10.43M) | (15.88M) | (15.03M) | (18.45M) | (17.25M) |
| Capital Expenditures | (814.74K) | (153.42K) | (224.1K) | (211.8K) | (162.14K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 933 | 0 | 0 | 0 |
| Other Investing Activities | 0 | (165) | 0 | 0 | 138 |
| Investing Cash Flow | (814.74K) | (152.65K) | (224.1K) | (211.8K) | (162K) |
| Debt Repayment | (936.59K) | 4.98M | 2.98M | 4.95M | 6M |
| Common Stock Issued | 20.37M | (85.92K) | 6.97M | 25.88M | 10.15M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 7.1M | 0 | 0 | 0 | (382) |
| Financing Cash Flow | 26.54M | 4.9M | 9.95M | 30.82M | 16.15M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 15.3M | (11.14M) | (5.3M) | 12.16M | (1.26M) |
| Free Cash Flow | (11.25M) | (16.04M) | (15.26M) | (18.66M) | (17.41M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$22.4M
+ D&A$540.9K
+ Stock-Based Comp$0
+ Deferred Tax$0
+ Working Capital$830.9K
+ Other Non-Cash$3.8M
= Operating Cash Flow-$17.2M
- Capex-$162.1K
= Free Cash Flow-$17.4M
Analysis
FY2025 free cash flow is -$17.4M. FCF conversion is 77.5% of net income. Operating cash flow was -$17.2M, with capex of -$162.1K. The largest bridge item is Other Non-Cash at $3.8M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 13, 2026 | |
| 424B3 | 424B3 filing | Nov 13, 2026 | |
| 8-K | Current report | Nov 13, 2026 | |
| 8-K | Current report | Nov 10, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 2, 2026 |
Does CING generate free cash flow?
Cingulate Inc. (CING) generated -$17.41M of free cash flow in fiscal 2025.
How much operating cash flow does CING produce?
Operating cash flow was -$17.25M, before capital expenditures of $162,138.00.
Continue the stock analysis
Jump to another research area for this company.